| |
Release Date: December 1, 2006
Expiration Date: October 31, 2008
Activity Code: 09HC02
Target Audience
This activity is designed for physicians
and nurses, and for other health care
professionals in New Jersey who are
involved in the care of persons with
HIV/AIDS.
Statement of Need
There have been recent changes in recommendations
for immunizations for HIV infected children
and adolescents. Several new vaccines
have been developed and FDA approved such
as Menactra, Gardasil and RotaTeq vaccine. In
addition to new vaccines, recommendation
for older vaccines such as influenza have
recently changed. Pediatric immunizations
are a vital part of preventing the serious
sequelae of many childhood infectious
diseases. Since HIV-infected children
are immunocompromised, it is important
for the physicians and other healthcare
providers caring for these children to
provide them with appropriate immunizations
according to the schedule recommended
by the CDC’s Advisory Committee
on Immunization Practices (ACIP). This
paper provides recommendations on immunizations
and alternatives for primary infectious
disease prevention for children and adolescents
infected with HIV. The information
presented in this activity will enable
physicians, nurses, and occupational health
administrators to develop and implement
appropriate screening and intervention
for pregnant women with HIV/AIDS, to prevent
transmission to their babies.
Learning Objectives
Upon completion of this learning activity, the reader should be able to:
- Understand current immunization recommendations
for HIV-infected children and adolescents.
- Describe contra-indications for immunizations
for HIV-infected persons.
Method of Instruction
Participants
should read the learning objectives and
review the activity in its entirety. After
reviewing the material, complete the self-assessment
test consisting of a series of multiple-choice
and True/ False questions. Upon completing
this activity as designed and achieving
a passing score of 70% or more on the
self-assessment test, participants will
receive a credit letter and the test
answer key four (4) weeks after receipt
of the self-assessment test, registration,
and evaluation materials. Estimated
time to complete this activity as designed
is 1.5 hours.
Accreditation
Physicians: UMDNJ–Center for Continuing and Outreach Education
is accredited by the Accreditation Council for Continuing Medical Education
to provide continuing medical education for physicians. UMDNJ–Center
for Continuing and Outreach Education designates this educational activity
for a maximum of 1.5 AMA PRA category 1 creditsTM toward the AMA Physician’s
Recognition Award. Each physician should
claim only those credits that he/she actually
spent in the activity.
Nurses: The University of Medicine
and Dentistry of New Jersey-Continuing
Education and Outreach Education is an
approved provider of continuing nursing
education by the New Jersey State Nurses
Association, Provider Number P173-10/06-09.
New Jersey State Nurses Association is
accredited by the American Nurses Credentialing
Center's Commission on Accreditation. Provider
Approval is valid through October 31,
2009. This activity is awarded 1.5 contact
hours.
UMDNJ-Center
for Continuing and Outreach Education
is an approved provider of continuing
education by the California Board of Registered
Nursing, Provider Number CEP 13780 for
a maximum of 1.5 contact hours for this
activity.
Review
The activity was prepared in accordance
with the ACCME Essentials. This activity
was reviewed for relevance, accuracy
of content, balance of presentation,
and time required for participation
by Patricia Kloser, MD, MPH. This activity
was reviewed for relevance, accuracy
of content, balance of presentation,
and time required for participation
by Bonnie Abedini, BSN, MS; Mary C.
Krug RN, MSN, APN-C; and Debbie Y. Mohammed,
MS, APRN-BC, ACRN.
Faculty
Sindy M. Paul, MD, MPH,
is Medical Director for the New
Jersey Department of Health and
Senior Services (NJDHSS), Division
of HIV/AIDS Services; Assistant
Clinical Professor at the University
of Medicine and Dentistry of
New Jersey (UMDNJ);and President,
New Jersey Board of Medical Examiners.
She is also director of the Preventive
Medicine Public Health Residency.
Linda Berezny, RN,
is Supervising Program Development
Specialist, with the Division
of HIV/AIDS Services, New Jersey
Department of Health and Senior
Services (NJDHSS)
Colin T. Campbell, DVM, CPM,
is the Senior Public Health Veterinarian
in the Communicable Disease Service, NJDHSS.
Nancy M. Borsuk, RN,MPH,
is the Surveillance and Perinatal Hepatitis
B Project Coordinator, Vaccine Preventable
Disease Prevention Program, NJDHSS
Christina G.Tan, MD,
is Deputy State Epidemiologist/Medical
Director, Communicable Disease Service,
NJDHSS.
Matthew Aibel is a student
at Washington University in St. Louis.
Disclosure
In accordance with the disclosure policies
of UMDNJ and to conform with ACCME and
FDA guidelines, all program faculty
are required to disclose to the activity
participants: 1) the existence of any
financial interest or other relationships
with the manufacturers of any commercial
products/devices, or providers of commercial
services, that relate to the content
of their presentation/material, or the
commercial contributors of this activity,
that could be perceived as a real or
apparent conflict of interest; and 2)
the identification of a commercial product/device
that is unlabeled for use or an investigational
use of a product/ device not yet approved.
Faculty Disclosure Declarations
Patricia Kloser, MD, MPH (Field Tester
and Activity Director) has the following
financial relationships to disclose: Speaker’s Bureau:
GlaxoSmithKline, Roche;Consultant:Gilead,
Boehringer Ingleheim. The following have
no financial relationships to disclose:
faculty: Sindy M.Paul, MD, MPH; Linda
Berezny, RN, Colin T. Campbell, DVM, CPM,
Nancy M. Borsuk, RN,MPH, Christina G.Tan,
MD, and Matthew Aibel; and field testers:
Bonnie Abedini, BSN, MS;Mary C.Krug, RN,
MSN, APN-C; and Debbie Y. Mohammed, MS, APRN-BC, ACRN.
Off-Label Usage Disclosure
This activity does not contain information
of commercial products/devices that are
unlabeled for use or investigational uses
of products not yet approved.
Disclaimer
The views expressed in this activity
are those of the faculty. It should
not be inferred or assumed that they
are expressing the views of NJDHSS-Division
of HIV/AIDS Services, UMDNJ, or any
manufacturer of pharmaceuticals. The
drug selection and dosage information
presented in this activity are believed
to be accurate. However, participants
are urged to consult the full prescribing
information on any agent(s) presented
in this activity for recommended dosage,
indications, contraindications, warnings,
precautions, and adverse effects before
prescribing any medication. This is
particularly important when a drug
is new or infrequently prescribed.
Copyright © 2006 UMDNJ-Center for
Continuing and Outreach Education. All
rights reserved including translation
into other languages. No part of this
activity may be reproduced or transmitted
in any form or by any means, electronic
or mechanical, including photocopying,
recording, or any information storage
and retrieval systems, without permission
in writing from UMDNJ-Center for Continuing
and Outreach Education.
Grantor Acknowledgement
This activity is supported by an educational
grant from NJDHSS Division of HIV/AIDS
Services through a MOA titled “Education
and Training for Physicians and other
Healthcare Professionals in the Diagnosis
and Treatment of HIV/AIDS.” |
|
